James V. Freeman, MD, MPH, MS

James V. Freeman MD, MPH, MS, is a cardiologist who specializes in the treating cardiac arrhythmias. He is nationally known for his expertise performing specialized arrhythmia procedures including ablation of complex arrhythmias (supraventricular tachycardias, atrial fibrillation and flutter, and ventricular tachycardia), left atrial appendage occlusion, and placing implantable cardiac devices such as pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices.

Dr. Freeman is director of the Cardiac Electrophysiology Laboratories for Yale New Haven Health and the director of the Yale Atrial Fibrillation Program. He has a Masters in Public Health degree with a concentration in biostatistics and epidemiology from Johns Hopkins and a Masters of Science degree in health services research from Stanford.

Dr. Freeman has published extensively on topics of comparative effectiveness, cost-effectiveness, and clinical outcomes with cardiac arrhythmias. He has served as the lead researcher on studies funded by the National Institutes of Health, the American College of Cardiology, and the American Heart Association to study the safety and effectiveness of therapies for the prevention and treatment of atrial fibrillation, ventricular fibrillation/tachycardia, sudden cardiac death, stroke and heart failure.